• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Puyu,SUN Shuqing,ZHENG Hua.Exploring the material basis and mechanisms of Rubus suavissimus S. Lee against diabetic nephropathy through network pharmacology and in vivo experiments[J].Journal Of Pharmaceutical Research,2025,44(11):1,056-10,631,138[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 1973times   Download 826次 QR Code for this article
Scan with your phone!
基于网络药理学及体内实验探讨瑶山甜茶抗糖尿病肾病的物质基础及作用机制
王璞钰1,孙书晴2,郑华1
Font:Larger+|Default|Smaller-
(1.广西医科大学生命科学研究院,广西 南宁 530021;2.广西医科大学第一临床医学院,广西 南宁 530021)
摘要:
目的 探究瑶山甜茶(Rubus suavissmus S. Lee,RS)治疗糖尿病肾病(Diabetic Nephropathy,DN)的物质基础与作用机制。方法 UPLC-Q-TOF-MS分析瑶山甜茶水提液成分,数据库检索糖尿病肾病的潜在靶点,构建蛋白互作网络,GO、KEGG通路富集分析,对筛选所得核心成分与核心靶点进行分子对接和动物实验验证。结果 从瑶山甜茶中鉴定出47个化学成分和744个潜在活性成分靶点,372个糖尿病肾病靶点。筛选出山柰酚(Kaempferol)和槲皮素(Quercetin)2个关键成分和TP53、SRC、STAT3、PIK3CA、PIK3R1、HSP90AA1共6个核心靶点。KEGG通路富集分析得到PI3K-AKT通路、MAPK通路等通路与糖尿病肾病密切相关。分子对接结果和动物实验结果显示,山柰酚与核心靶点PIK3R1具有良好的结合作用,并能有效降低糖尿病肾病大鼠血糖和尿素氮,且能减轻模型组大鼠肾小管扩张和肾小球纤维化。结论 山柰酚可能是瑶山甜茶治疗糖尿病肾病的物质基础,可能通过调控PI3K-AKT通路、MAPK通路中的细胞自噬及线粒体自噬相关蛋白发挥抗糖尿病肾病作用。
关键词:  瑶山甜茶  糖尿病肾病  网络药理学  超高效液相色谱四极杆飞行时间串联质谱  山柰酚
DOI:10.13506/j.cnki.jpr.2025.11.003
基金项目:国家自然科学基金项目(No.82360833);广西自然科学基金项目(No.2023GXNSFAA026457)
Publication Date:November 25, 2025
Exploring the material basis and mechanisms of Rubus suavissimus S. Lee against diabetic nephropathy through network pharmacology and in vivo experiments
WANG Puyu1,SUN Shuqing2,ZHENG Hua1
(1.Life Sciences Institute, Guangxi Medical University, Nanning 530021, China; 2.The First Affiliated Medical College,Guangxi Medical University, Nanning 530021, China)
Abstract:
Objective To explore the material basis and mechanism of Yaoshan sweet tea (Rubus suavissimus S. Lee, RS) in treating diabetic nephropathy. Methods UPLC-Q-TOF-MS analysis of RS aqueous extract components, database screening for Diabetic Nephropathy potential targets, construction of protein-protein interaction networks, GO and KEGG pathway enrichment analyses, followed by molecular docking and in vivo experimental validation of screened core components and key targets. Results A total of 47 chemical components and 744 potential active ingredient targets were identified in RS, along with 372 diabetic nephropathy targets. Two key components, kaempferol and quercetin, were screened out, along with six core targets: TP53, SRC, STAT3, PIK3CA, PIK3R1, and HSP90AA1. KEGG pathway enrichment analysis revealed that the PI3K-AKT signaling pathway, MAPK pathway, and others were closely associated with diabetic nephropathy. Molecular docking results and animal experiments demonstrated that kaempferol exhibited strong binding affinity with the core target PIK3R1. Additionally, it effectively reduced blood glucose and urea nitrogen levels in diabetic nephropathy rats, while alleviating renal tubular dilation and glomerular fibrosis in the model group. Conclusion Kaempferol may serve as the primary active component of RS against DN, potentially exerting therapeutic effects by regulating autophagy- and mitophagy-related proteins in PI3K-AKT and MAPK signaling pathways.
Key words:  Rubus suavissmus S. Lee  Diabetic nephropathy  Network pharmacology  UPLC-Q-TOF-MS  Kaempferol
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.